نتائج البحث

The ICPO Foundation—on the way toward collaborative growth of theranostics.

• Authors : Baum, Richard P.¹ (AUTHOR); Mailman, Josh² (AUTHOR); Jaume, Odile³ (AUTHOR)

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2022, Vol. 49 Issue 2, p443-444. 2p.

تفاصيل العنوان

Activity quantification and dosimetry in radiopharmaceutical therapy with reference to 177Lutetium

• Authors : Keamogetswe Ramonaheng; Milani Qebetu; Honest Ndlovu

Subjects: 177Lutetium; SPECT; PET

• Source: Frontiers in Nuclear Medicine, Vol 4 (2024)

تفاصيل العنوان

Impressive Response to TANDEM Peptide Receptor Radionuclide Therapy with 177 Lu/ 225 AcDOTA-LM3 Somatostatin Receptor Antagonist in a Patient with Therapy-Refractory, Rapidly Progressive Neuroendocrine Neoplasm of the Pancreas.

• Authors : Perrone, Elisabetta^1,2 (AUTHOR) ; Ghai, Kriti¹ (AUTHOR) ; Eismant, Aleksandr¹ (AUTHOR)

• Source: Diagnostics (2075-4418). May2024, Vol. 14 Issue 9, p907. 7p.

تفاصيل العنوان

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles.

• Authors : Baum, Richard P.^1,2 (AUTHOR); Fan, Xin^3,4,5,6 (AUTHOR); Jakobsson, Vivianne^3,4,7 (AUTHOR)

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Mar2024, Vol. 51 Issue 4, p1136-1146. 11p.

تفاصيل العنوان

177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer.

• Authors : Perrone, Elisabetta^1,2 ; Ghai, Kriti¹; Eismant, Aleksandr¹

• Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p557-562. 6p.

تفاصيل العنوان

Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).

• Authors : Kratochwil, Clemens¹ (AUTHOR) ; Fendler, Wolfgang P.² (AUTHOR); Eiber, Matthias³ (AUTHOR)

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2023, Vol. 50 Issue 9, p2830-2845. 16p. 1 Chart.

تفاصيل العنوان

Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with 177 Lu-PSMA and Combined 225 Ac- and 177 Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation.

• Authors : Langbein, Thomas^1,2 (AUTHOR) ; Kulkarni, Harshad R.^1,3 (AUTHOR); Schuchardt, Christiane¹ (AUTHOR)

• Source: Diagnostics (2075-4418). Aug2022, Vol. 12 Issue 8, p1926-N.PAG. 15p.

تفاصيل العنوان

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [ 68 Ga]Ga-DATA 5m.SA.FAPi.

• Authors : Greifenstein, Lukas¹ (AUTHOR) ; Kramer, Carsten S.¹ (AUTHOR); Moon, Euy Sung² (AUTHOR)

• Source: Pharmaceuticals (14248247). Aug2022, Vol. 15 Issue 8, p1000-1000. 14p.

تفاصيل العنوان

Immuno-Imaging (PET/SPECT)–Quo Vadis?

• Authors : Kramer, Carsten S.¹ (AUTHOR) ; Dimitrakopoulou-Strauss, Antonia² (AUTHOR)

Subjects: *SINGLE-photon emission computed tomography; *CARDIAC radionuclide imaging; *SMALL molecules

• Source: Molecules. May2022, Vol. 27 Issue 10, p3354-3354. 10p.

تفاصيل العنوان

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).

• Authors : Ahmadzadehfar, Hojjat^1,2 (AUTHOR) ; Rahbar, Kambiz³ (AUTHOR); Baum, Richard P.⁴ (AUTHOR)

• Source: European Journal of Nuclear Medicine & Molecular Imaging. 2021, Vol. 48 Issue 1, p113-122. 10p. 3 Charts, 3 Graphs.

تفاصيل العنوان